THE WOODLANDS, Texas--(BUSINESS WIRE)--Sept. 18, 2006--Repros Therapeutics Inc. (NasdaqGM:RPRX) (PCX:RPRX) announced today that the Form S-3 shelf registration statement it filed on September 5, 2006 with the Securities and Exchange Commission for up to 5,000,000 shares of common stock was declared effective as of September 15, 2006 and will remain effective for three years.
